| 2009 |
Teti A, Zallone A. Do osteocytes contribute to bone mineral homeostasis? osteocytic osteolysis revisited. Bone. January 2009;44(1):11-16. |
30 |
30 |
| 2021 |
Norwood I, Szondi D, Ciocca M, Coudert A, Cohen-Solal M, Rucci N, Teti A, Maurizi A. Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2: preclinical and clinical implications. Bone. March 2021;144:115828. |
2 |
2 |
| 2022 |
Teti A. Early treatment of osteopetrosis: paradigm shift to marrow cell transplantation. Bone. November 2022;164:116512. |
0 |
0 |
| 2023 |
Teti A, Whyte MP. Osteopetrosis: gene-based nosology and significance. Bone. October 2023;175:116854. |
0 |
0 |
| 2020 |
Loftus A, Cappariello A, George C, Ucci A, Shefferd K, Green A, Paone R, Ponzetti M, Delle Monache S, Muraca M, Teti A, Rucci N. Extracellular vesicles from osteotropic breast cancer cells affect bone resident cells. J Bone Miner Res. February 2020;35(2):396-412. |
0 |
0 |
| 2020 |
Dennis EP, Edwards SM, Jackson RM, Hartley CL, Tsompani D, Capulli M, Teti A, Boot‐Handford RP, Young DA, Piróg KA, Briggs MD. CRELD2 is a novel LRP1 chaperone that regulates noncanonical WNT signaling in skeletal development. J Bone Miner Res. August 2020;35(8):1452-1469. |
0 |
0 |